One-Month Treatment for Latent Tuberculosis Why aren’t we using it?

One-month treatment for latent tuberculosis.

Why aren't we using it? (Hint: We should.)

voices.nejm.org/doi/full/10....

Troubled waters: Legionella pneumonia in the modern era A study in CID looked at clinical features and predictors of mortality for Legionella pneumonia. Read IDSA's Journal Club review by Christopher J. Graber, MD, MPH, FIDSA.

On IDSA’s & HIVMA’s Science Speaks blog: A study in CID looked at clinical features and predictors of mortality for Legionella pneumonia across a large integrated health system. Read IDSA’s Journal Club review by Christopher J. Graber, MD, MPH, FIDSA: https://bit.ly/3NOpG4M

Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve Advances in care for patients with human immunodeficiency virus have simplified the management of infectious disease–related conditions, yet primary care h

Should ID provide primary care to patients with HIV?

Point and counter point in @cidjournal.bsky.social

Work with primary care for PLWH: doi.org/10.1093/cid/...

Work as primary care for PLWH: doi.org/10.1093/cid/...

#IDSky

Staying in the Tent: Why Infectious Disease Physicians Remain Essential to Human Immunodeficiency Virus Primary Care Infectious disease (ID) specialists provide consolidated, patient-centered HIV primary care. Workforce shortages, patient preferences, and regional HIV dis

the counterpoint:

academic.oup.com/cid/advance-...

Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to Evolve Advances in care for patients with human immunodeficiency virus have simplified the management of infectious disease–related conditions, yet primary care h

Would love to spark a discussion with our recent point-counterpoint in CID on the future of ID-HIV primary care.

My colleagues and I argue that we AND our patients are better off leaving the intricacies of primary care to those who do it more than we do.

academic.oup.com/cid/advance-...

Congrats to the incoming class! Where can the fellowship PDs request their baseball cards?

Airtable | Everyone's app platform Airtable is a low-code platform for building collaborative apps. Customize your workflow, collaborate, and achieve ambitious outcomes. Get started for free.

does this work?

airtable.com/appzPcoBRgsm...

priority list signup for non-US physicians and non-physician folks in healthcare: airtable.com/appzPcoBRgsmUX…

what I like about Roon so far:
1. More back-and-forth discussion
2. Ability to follow certain topics in “spaces” (e.g., AI in medicine, health policy, med ed, medical reasoning)
3. You can’t tell how many followers you have (less clout-chasing and virtue signaling)
4. No bots or trolls

100% biggest limitation right now. Hopefully temporary (remember when Bluesky was invite-only?)

So far it’s limited to US-based physicians (need NPI) but goal is to add others (need our ID pharmacists and international colleagues!) over time

Roon for Medical Experts Where the world’s best physicians share knowledge and advance medicine—together.

Join here!

www.roon.com?utm_campaign...

Remember the glory days of #IDTwitter? Want to have discussions with your colleagues without sifting through the slop of X and the echo chambers of Bluesky? Come join what we are building over at Roon!

Bruin. Doin’ us proud.

USAJOBS connects job seekers with federal jobs across the United States and around the world as the official employment site for the federal government The Clinical Pharmacist Specialist for Infectious Diseases must be a licensed pharmacist, have expert knowledge of infectious disease/antimicrobial medication therapy and management, and have an exper...

Are you an ID pharmacist currently in the VA system who wants to live in an awesome city and work with awesome people?

Look no further.

www.usajobs.gov/job/858066800

Antibiotics in community-acquired pneumonia when respiratory viruses are detected: Adding more fuel to the fire? A study in CID examined associations between antibiotic use and outcomes in patients hospitalized with community-acquired pneumonia and positive respiratory viral assays.

My latest for IDSA Journal Club: a review of a recent CID paper that finds similar outcomes in CAP patients with pos viral testing when treated with 0-2d vs 5-7d abx, adding fuel to recent IDSA-ATS controversy.

www.idsociety.org/science-spea...

just referred to a smoldering leukocytosis as “low-key” on rounds today…not sure if I’m chopped, cringe, or goated

I did not have @mmpharmd.bsky.social making a 6-7 reference in a CID article on my bingo card of things that were going to make my day today but here we are

academic.oup.com/cid/advance-...

did ABIM really just send me my LKA Wrapped?

Anti-staphylococcal penicillins versus cefazolin for methicillin-susceptible S. aureus bacteremia: Is there a role for determining blaZ type? A study in The Lancet addressed cloxacillin versus cefazolin for methicillin-susceptible S. aureus bacteremia. Read IDSA’s Journal Club review by Christopher J. Graber.

we’re talkin’ CloCeBa at @idsainfo.bsky.social Journal Club this month! Do we need to think about adding blaZ type to rapid diagnostic panels for MSSA bacteremia?

www.idsociety.org/science-spea...

Restoring Confidence in Public Health | NEJM A confluence of interrelated factors has put past progress in public health at serious risk in the United States. How did we get here, and what can public health professionals do about it?

The 6 “coms” of why we are losing the battle over public health: complacency, commitment, commercialism, complexity, communication, and comportment

www.nejm.org/doi/full/10....

Amplifying Our Voices: Fostering Advocacy in Infectious Diseases Fellowship This white paper, devised from the Infectious Diseases Society of America's National Training Program Director annual meeting, outlines practical strategie

With UW’s Dr Paul Pottinger and others, new discussion re: fostering ID advocacy in ID fellowship.

They note:
Policies with a negative impact on ID clinical care, public health, & research underscore the importance of mobilizing the field of ID to advocacy

academic.oup.com/ofid/advance... #IDSky

5. The Learner (redux): the late career person who no longer has to play hard at the game and is at the meeting for the science and to have awesome dinners with friends.

Making it to this stage is the aspirational goal.

4. The Leader: the mid to late career person who mostly goes to meet with other key Leaders to plan grants, policies, and initiatives. Only catches a few educational sessions. Comes late and leaves early.

3. The Organizer: the midcareer person involved in planning sessions, moderating, leading symposia, getting people to meet who need to meet. Lucky to make it to half the educational stuff they aren’t involved in.

2. The Presenter: the trainee or early career person who has a poster or oral presentation, still learns and absorbs most of the meeting, but the presentation is the focus.

beginning to realize the stages of @idweek.bsky.social attendance according to career stage:

1. The Learner: the student/resident/fellow that goes to learn and absorb.

the day that AI can do schedule-making better than me is the day my work is done as a PD…it’s gonna be a while

Transplant Infectious Diseases Career Development Position 2026-2027 University of California, Los Angeles is hiring. Apply now!

Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380

Well done to all the teams! Time for everyone to start making plans for BugBowl 2026 in DC!